SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cambridge Antibody Technology Group -- Ignore unavailable to you. Want to Upgrade?


To: nigel bates who wrote (283)9/18/2002 11:27:14 AM
From: tuck  Respond to of 625
 
>>8:33AM Abbott Labs upgraded at Merrill Lynch (ABT) 38.59: Merrill Lynch upgrades to BUY from Neutral due to more confidence in the timing of the D2E7 approval; says rev growth could accelerate to about 10% in 2003 if a panel recommendation portends FDA approval by the end of Q1. Price target is $50.<<

Cheers, Tuck